(Q35573445)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25749935%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

review article

1 reference

title

Gut microbiota: a key player in health and disease. A review focused on obesity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25749935%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

Patricia Pérez-Matute

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25749935%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

M J Villanueva-Millán

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25749935%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

J A Oteo

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25749935%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

8 March 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25749935%20AND%20SRC:MED&resulttype=core&format=json

Journal of Physiology and Biochemistry

2 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25749935%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25749935%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25749935%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

509-525

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25749935%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s13105-015-0390-3

2 March 2020

exact match

0 references

cites work

Frequency of Firmicutes and Bacteroidetes in gut microbiota in obese and normal weight Egyptian children and adults

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Modulation of carbohydrate metabolism and peptide hormones by soybean isoflavones and probiotics in obesity and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Antiobesity and lipid-lowering effects of Bifidobacterium spp. in high fat diet-induced obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Enterotypes of the human gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

The gut microbiota as an environmental factor that regulates fat storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Host-bacterial mutualism in the human intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Mechanisms underlying the resistance to diet-induced obesity in germ-free mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Influence of stressor-induced nervous system activation on the intestinal microbiota and the importance for immunomodulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Male mice that lack the G-protein-coupled receptor GPR41 have low energy expenditure and increased body fat content.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Differences in gut microbiota composition between obese and lean children: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

GPR43/FFA2: physiopathological relevance and therapeutic prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Microbial translocation across the GI tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Metagenome and metabolism: the tissue microbiota hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Metabolic endotoxemia initiates obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Dietary phytoestrogens activate AMP-activated protein kinase with improvement in lipid and glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Human colonic microbiota associated with diet, obesity and weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Exercise prevents weight gain and alters the gut microbiota in a mouse model of high fat diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

A taxonomic signature of obesity in the microbiome? Getting to the guts of the matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Prebiotics and probiotics: the prevention and reduction in severity of atopic dermatitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Role of the gut microbiota in defining human health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Metagenomic analysis of the human distal gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Gut flora in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

From the gut to the peripheral tissues: the multiple effects of butyrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Antibiotic exposure in the first two years of life and development of asthma and other allergic diseases by 7.5 yr: a dose-dependent relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Obesity and diabetes in the developing world--a growing challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Therapeutic modulation of gut microbiota: current clinical applications and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Metatranscriptomics of the human oral microbiome during health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Control of pathogens and pathobionts by the gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Role of the gut microbiota in the development and function of lymphoid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Obesity alters gut microbial ecology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Microbial ecology: human gut microbes associated with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Diversity, stability and resilience of the human gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Microbial endocrinology in the microbiome-gut-brain axis: how bacterial production and utilization of neurochemicals influence behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Pharmacokinetics and metabolism of dietary flavonoids in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Diet-induced metabolic improvements in a hamster model of hypercholesterolemia are strongly linked to alterations of the gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Cerebral low-molecular metabolites influenced by intestinal microbiota: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Biodiversity and functional genomics in the human microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

External influence of early childhood establishment of gut microbiota and subsequent health implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Beneficial effect of oral administration of Lactobacillus casei strain Shirota on insulin resistance in diet-induced obesity mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

The function of our microbiota: who is out there and what do they do?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Short-term effect of antibiotics on human gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Are stool samples suitable for studying the link between gut microbiota and obesity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Microbial contact during pregnancy, intestinal colonization and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

The human intestinal microbiome at extreme ages of life. Dietary intervention as a way to counteract alterations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Interplay between weight loss and gut microbiota composition in overweight adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Lignan formation in man--microbial involvement and possible roles in relation to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

The gut microbiota, obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Therapeutic potential of fecal microbiota transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Prediction and quantification of bioactive microbiota metabolites in the mouse gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Translational research into gut microbiota: new horizons in obesity treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

An obesity-associated gut microbiome with increased capacity for energy harvest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Intestinal microbiota and faecal transplantation as treatment modality for insulin resistance and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

The interpersonal and intrapersonal diversity of human-associated microbiota in key body sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Human intestinal microbiota composition is associated with local and systemic inflammation in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Luminal administration ex vivo of a live Lactobacillus species moderates mouse jejunal motility within minutes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

The role of gut microbiota in drug response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Human gut microbiota in obesity and after gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-015-0390-3

Intestinal bacterial metabolism of flavonoids and its relation to some biological activities

21 January 2018

1 reference

12 December 2020

Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome

1 reference

12 December 2020

The gut-brain-axis as a target to treat stress-induced obesity

1 reference

12 December 2020

Epithelial cell growth and differentiation. III. Promoting diversity in the intestine: conversations between the microflora, epithelium, and diffuse GALT.

1 reference

12 December 2020

Modeling the impact of antibiotic exposure on human microbiota

1 reference

12 December 2020

Intestinal Bacterial Colonization Induces Mutualistic Regulatory T Cell Responses

1 reference

12 December 2020

The role of intestinal microbiota and the immune system.

1 reference

12 December 2020

Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats

1 reference

12 December 2020

Progress in the knowledge of the intestinal human microbiota

1 reference

12 December 2020

Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity

1 reference

12 December 2020

Is the gut microbiota a new factor contributing to obesity and its metabolic disorders?

1 reference

12 December 2020

Treatment of relapsing Clostridium difficile infection using fecal microbiota transplantation

1 reference

12 December 2020

Genotype-dependent response to energy-restricted diets in obese subjects: towards personalized nutrition

1 reference

12 December 2020

Involvement of the gut microbiota in the development of low grade inflammation associated with obesity: focus on this neglected partner.

1 reference

12 December 2020

Regulation of Energy Homeostasis by GPR41

1 reference

12 December 2020

Developmental microbial ecology of the neonatal gastrointestinal tract

1 reference

12 December 2020

How intestinal bacteria can promote HIV replication

1 reference

12 December 2020

Gut bacteria in health and disease

1 reference

12 December 2020

Dietary intake and bioavailability of polyphenols

1 reference

12 December 2020

10.1007/S13105-015-0390-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25749935%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference